Oncology PracticeGood chemo vs. bad chemo: When too much is a bad thingJune 28, 2022Renal Cell CarcinomaBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Oncology PracticeMy picks for best of ASCO 2022June 28, 2022ASCO Lung CancerASCO Breast CancerBreast CancerGenitourinary CancerGynecologic CancerLung CancerMetastatic Breast Cancer
Oncology PracticeEvidence still lacking that vitamins prevent CVD, cancer: USPSTFJune 24, 2022Preventive CareMixed TopicsAMLBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
Similar prognosis in pregnant vs. nonpregnant BC patients receiving chemotherapyJune 23, 2022Breast Cancer
Breast cancer: Epigallocatechin-3-gallate prevents dermatitis in patients receiving radiotherapyJune 23, 2022Breast Cancer
Metastatic BC and brain metastases: Etirinotecan pegol fails to improve survival in phase 3June 23, 2022Breast Cancer
Adjuvant radiotherapy less toxic in prone vs. supine position in BC patients with heavy breastsJune 23, 2022Breast Cancer
Advanced TNBC: Camrelizumab + apatinib and eribulin shows promise in heavily pretreated patientsJune 23, 2022Breast Cancer
Primary BC: Weekly vs. every-3-week nab-paclitaxel improves pCR but with higher toxicityJune 23, 2022Breast Cancer
Oncology PracticeBreast cancer less common in Black women, so why do more die?June 21, 2022Breast CancerDiversity in Medicine
Oncology PracticeThis breast tumor subtype disproportionately affects Black womenJune 21, 2022ASCO Breast CancerBreast CancerMetastatic Breast Cancer
